Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001415889-25-020462·Atlas Venture Fund X, L.P.
Schedule 13D ownership disclosure
IMAGENEBIO INC
Common Stock, $0.001 par value per share · CUSIP: 45175G207
Event date: 2025-07-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Atlas Venture Fund X, L.P.Reported CIK 0001628098
Shares: 241,800.00 · Class: 2.1%
- ATLAS VENTURE ASSOCIATES X, L.P.Reported CIK 0001742766
Shares: 241,800.00 · Class: 2.1%
- Atlas Venture Associates X, LLCReported CIK 0001742765
Shares: 241,800.00 · Class: 2.1%
- Atlas Venture Fund XI, L.P.Reported CIK 0001708269
Shares: 103,494.00 · Class: 0.9%
- Atlas Venture Associates XI, L.P.Reported CIK 0001780068
Shares: 103,494.00 · Class: 0.9%
- Atlas Venture Associates XI, LLCReported CIK 0001780067
Shares: 103,494.00 · Class: 0.9%
- Atlas Venture Opportunity Fund I, L.P.Reported CIK 0001759241
Shares: 72,885.00 · Class: 0.6%
- Atlas Venture Associates Opportunity I, L.P.Reported CIK 0001780065
Shares: 72,885.00 · Class: 0.6%
- Atlas Venture Associates Opportunity I, LLCReported CIK 0001780066
Shares: 72,885.00 · Class: 0.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-020462
- Form type
- SCHEDULE 13D/A
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Jul 29, 2025
- Reporting period
- Jul 25, 2025
- Description
- Schedule 13D beneficial ownership